HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 4, 2009, Pages 559-566

  Boscolo Rizzo, Paolo ^c   Da Mosto, Maria Cristina ^a   Fuson, Roberto ^a   Frayle Salamanca, Helena ^b   Trevisan, Rossana ^b   Del Mistro, Annarosa ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c NONE   (Italy)

Author keywords

Head neck cancer; HPV 16; Human papillomavirus (HPV); L83V; Prognosis

Indexed keywords

CISPLATIN; FLUOROURACIL; MESSENGER RNA; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; CONTINUOUS INFUSION; CONTROLLED STUDY; DNA SEQUENCE; ELECTRON THERAPY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SQUAMOUS CELL CARCINOMA; UPPER AERODIGESTIVE TRACT CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENETIC VARIATION; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PHARYNGEAL NEOPLASMS; RISK FACTORS; RNA, MESSENGER; RNA, VIRAL; SMOKING CESSATION;

EID: 61449124971     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0490-3     Document Type: Article

References (41)

1. G Badaracco C Rizzo B Mafera B Pichi D Giannarelli SS Rahimi 2007 Molecular analyses and prognostic relevance of HPV in head and neck tumours Oncol Rep 17 931 939
2. S Barra S Franceschi E Negri R Talamini C La Vecchia 1990 Type of alcoholic beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption Int J Cancer 46 1017 1020 10.1002/ijc.2910460612
3. FX Bosch S de Sanjosé 2002 Human papillomavirus in cervical cancer Curr Oncol Rep 4 175 183 10.1007/s11912-002-0079-y
4. BJ Braakhuis PJ Snijders WJ Keune CJ Meijer HJ Ruijter-Schippers CR Leemans 2004 Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 998 1006
5. K Butz C Geisen A Ullmann D Spitkovsky F Hoppe-Seyler 1996 Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis Int J Cancer 68 506 513 10.1002/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO;2-2
6. L Charfi T Jouffroy P de Cremoux N Le Peltier M Thioux P Fréneaux 2008 Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome Cancer Lett 260 72 78 10.1016/j.canlet.2007.10.028
7. AK Chaturvedi EA Engels WF Anderson ML Gillison 2008 Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 612 619 10.1200/JCO.2007.14.1713
8. BC Das JK Sharma V Gopalakrishna UK Luthra 1992 Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions J Gen Virol 73 2327 2336 10.1099/0022-1317-73-9-2327
9. A Del Mistro L Bonaldi R Bertorelle D Minucci M Franzetti A Cattelan 2001 Genital human papillomavirus types in immunocompetent and immunodepressed women in Northeast Italy: prevalence and cytomorphological correlations J Low Genit Tract Dis 5 12 20 10.1046/j.1526-0976.2001.51003.x
10. A Del Mistro H Frayle-Salamanca R Trevisan R Bertorelle A Parenti E Bonoldi 2006 Human papillomavirus typing of invasive cervical cancers in Italy Infect Agent Cancer 1 9 10.1186/1750-9378-1-9
11. G D'Souza AR Kreimer R Viscidi M Pawlita C Fakhry WM Koch 2007 Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 1944 1956 10.1056/NEJMoa065497
12. C Fakhry WH Westra S Li A Cmelak JA Ridge H Pinto 2008 Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 261 269 10.1093/jnci/djn011
13. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 581 592 10.1093/annonc/mdl498
14. RL Ferris I Martinez N Sirianni J Wang A López-Albaitero SM Gollin 2005 Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis Eur J Cancer 41 807 815 10.1016/j.ejca.2004.11.023
15. ML Gillison WM Koch RB Capone M Spafford WH Westra L Wu 2000 Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 709 720 10.1093/jnci/92.9.709
16. ML Gillison G D'Souza W Westra E Sugar W Xiao S Begum 2008 Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 407 420 10.1093/jnci/djn025
17. L Hammarstedt H Dahlstrand D Lindquist L Onelöv M Ryott J Luo 2007 The incidence of tonsillar cancer in Sweden is increasing Acta Otolaryngol 127 988 992 10.1080/00016480601110170
18. M Hoffmann T Görögh S Gottschlich C Lohrey W Rittgen P Ambrosch 2005 Human papillomaviruses in head and neck cancer: 8-year-survival analysis of 73 patients Cancer Lett 218 199 206 10.1016/j.canlet.2004.09.027
19. CS Hollenbeak BC Stack Jr SM Daley JF Piccirillo 2007 Using comorbidity indexes to predict costs for head and neck cancer Arch Otolaryngol Head Neck Surg 133 24 27 10.1001/archotol.133.1.24
20. I Kraus T Molden R Holm AK Lie F Karlsen GB Kristensen 2006 Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas J Clin Microbiol 44 1310 1317 10.1128/JCM.44.4.1310-1317.2006
21. AR Kreimer GM Clifford P Boyle S Franceschi 2005 Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 467 475 10.1158/1055-9965.EPI-04-0551
22. P Leone DT Fleming AW Gilsenan L Li S Justus 2004 Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States Sex Transm Dis 31 311 316 10.1097/01.OLQ.0000123651.84697.D6
23. H Lichtig M Algrisi LE Botzer T Abadi Y Verbitzky A Jackman 2006 HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6 Virology 350 216 227 10.1016/j.virol.2006.01. 038
24. K Lindel KT Beer J Laissue RH Greiner DM Aebersold 2001 Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma Cancer 92 805 813 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9
25. T Molden I Kraus H Skomedal T Nordstrom F Karlsen 2007 PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses J Virol Methods 142 204 212 10.1016/j.jviromet.2007.01. 036
26. C Muir L Weiland 1995 Upper aerodigestive tract cancers Cancer 75 1 Suppl 147 153 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0. CO;2-U
27. RJ Nobre LP de Almeida TC Martins 2008 Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original algorithm J Clin Virol 42 13 21 10.1016/j.jcv.2007.11.021
28. C Pelucchi S Gallus W Garavello C Bosetti C La Vecchia 2006 Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver Alcohol Res Health 29 193 198
29. J Pintos EL Franco MJ Black J Bergeron M Arella 1999 Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract Cancer 85 1903 1909
30. A Psyrri D DiMaio 2008 Human papillomavirus in cervical and head-and-neck cancer Nat Clin Pract Oncol 5 24 31 10.1038/ncponc0984
31. CC Ragin E Taioli 2007 Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis Int J Cancer 121 1813 1820 10.1002/ijc.22851
32. S Riethdorf RE Friedrich C Ostwald M Barten P Gogacz KK Gundlach 1997 p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study J Oral Pathol Med 126 315 321 10.1111/j.1600-0714.1997.tb00222.x
33. SR Schwartz B Yueh JK McDougall JR Daling SM Schwartz 2001 Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study Otolaryngol Head Neck Surg 125 1 9 10.1067/mhn.2001. 116979
34. Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, International Union Against Cancer, Geneva
35. EM Sturgis PM Cinciripini 2007 Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110 1429 1435 10.1002/cncr.22963
36. B Suligoi M Cusan P Santopadre G Palù S Catania G Girelli 2000 HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum Sex Transm Infect 76 213 214 10.1136/sti.76.3.213
37. Tommasino M (ed) (1997) Papillomaviruses in human cancer: the role of E6 and E7 oncoproteins. Molecular Biology Intelligence Unit series. Landes, Austin
38. ML Tornesello ML Duraturo I Salatiello L Buonaguro S Losito G Botti 2004 Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer J Med Virol 74 117 126 10.1002/jmv.20154
39. SL Wain R Kier RT Vollmer EH Bossen 1986 Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases Hum Pathol 17 1158 1166 10.1016/S0046-8177(86)80422-1
40. PM Weinberger Z Yu BG Haffty D Kowalski M Harigopal J Brandsma 2006 Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 736 747 10.1200/JCO.2004.00.3335
41. F Xu MR Sternberg BJ Kottiri GM McQuillan FK Lee AJ Nahmias 2006 Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States JAMA 296 964 973 10.1001/jama.296.8.964